Search

Researchers at the University of Minnesota have identified Lassa fever as a priority disease for epidemic preparedness, prompting the need for effective medical countermeasures such as diagnostics, therapeutics, and vaccines. Current limitations in diagnostic testing and treatment options, including the controversial effectiveness of ribavirin, highlight the urgency for advancements in medical countermeasure development. The research outlines key priorities for the development of Lassa fever medical countermeasures to be readily available in endemic areas by the end of the decade, emphasizing the importance of ongoing epidemiological and behavioral studies. [Extracted from the article]

A recent study conducted at the University of Minnesota highlights the urgent need for medical countermeasures to prevent and treat Nipah virus infections, which have high fatality rates and no current treatments or vaccines. The research outlines key priorities for developing diagnostics, therapeutics, and vaccines to enable effective emergency responses to Nipah virus outbreaks. This peer-reviewed study emphasizes the importance of achieving strategic goals in the next six years to ensure rapid and effective tools for combating Nipah virus and related henipaviruses. [Extracted from the article]